Can I read Roflumilast: PDE-4 Inhibitor for Asthma & COPD on EtoBox?

Roflumilast: PDE-4 Inhibitor for Asthma & COPD by Tulus Java is a document available to read on EtoBox.

What is Roflumilast: PDE-4 Inhibitor for Asthma & COPD about?

This document reviews the pharmacology, efficacy, and safety of roflumilast, a selective phosphodiesterase-4 inhibitor, for treating asthma and chronic obstructive pulmonary disease (COPD). Roflumilast has shown potential anti-inflammatory effects and a favorable safety profile in clinical trials, with ongoing research needed to confirm its therapeutic role. The drug is currently in Phase III trials in the US and is anticipated to be marketed under the brand name Daxas.

Author

Tulus Java

Language

EN